Analyst consensus rating
Aprea Therapeutics Analyst Rating: none
Direct answer
Aprea Therapeutics's consensus rating is none.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $3.55.
Forecast evidence checked September 9, 2026.
Get free Aprea Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.84
- Average price target
- $3.55
- High price target
- $5.00
- Low price target
- $1.20
- Low target gap
- +43.7%
- Target upside
- +325.1%
- High target gap
- +498.8%
- Target range width
- 455.1%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- September 9, 2026
- Valid through
- September 16, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Aprea Therapeutics?
Aprea Therapeutics has a verified none consensus. The same dataset has an average price target of $3.55.
How far are Aprea Therapeutics's low and high targets from the recorded price?
The low target implies +43.7%, while the high target implies +498.8%.
How many analysts are included in Aprea Therapeutics's consensus?
The verified consensus includes 4 analysts.
How is Aprea Therapeutics's target upside or downside calculated?
The average target of $3.55 is divided by the recorded price of $0.84, then one is subtracted to produce +325.1%. This does not guarantee a future return.
When was Aprea Therapeutics's analyst forecast verified?
The data was verified on 2026-09-09. The dataset is valid through 2026-09-16.